RCT for Yinqiaosan-Maxingganshitang in the Treatment of COVID-19

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a randomized, double-blinded, placebo-controlled clinical trial. This study is to evaluate the effectiveness and safety of Yinqiaosan-Maxingganshitang in the treatment of the major symptoms of mild and moderate COVID-19 patients by telemedicine.
Epistemonikos ID: f9908f70a88bbf899899e5901b70a3193475b6be
First added on: Mar 29, 2023